key: cord-0855615-88wcbhc3
authors: Guntur, Vamsi P.; Modena, Brian D.; Manka, Laurie A.; Eddy, Jared J.; Liao, Shu-Yi; Goldstein, Nir M.; Zelarney, Pearlanne; Horn, Carrie A.; Keith, Rebecca C.; Make, Barry J.; Petrache, Irina; Wechsler, Michael E.
title: Characteristics and outcomes of ambulatory patients with suspected COVID-19 at a respiratory referral center
date: 2022-04-07
journal: Respir Med
DOI: 10.1016/j.rmed.2022.106832
sha: daa054a1f189154c935a50149e3fb3dc7e0b74b9
doc_id: 855615
cord_uid: 88wcbhc3

SARS-CoV-2 continues to cause a global pandemic and management of COVID-19 in outpatient settings remains challenging. Objective: We sought to describe characteristics of patients with chronic respiratory disease (CRD) experiencing symptoms consistent with COVID-19, who were seen in a novel Acute Respiratory Clinic, prior to widely available testing, emergence of variants, COVID-19 vaccination, and post-vaccination (breakthrough) SARS-CoV-2 infections. Methods: Retrospective electronic medical record data were analyzed from 907 adults with presumed COVID-19 seen between March 16, 2020 and January 7, 2021. Data included demographics, comorbidities, medications, vital signs, laboratory tests, pulmonary function tests, patient disposition, and co-infections. The overdispersed data (aod) R package was used to create a logit model using COVID-19 diagnosis by PCR as the dichotomous outcome variable. Univariate, conventional multivariate and elastic net machine learning were used to analyze data. Results: Male gender, elevated baseline temperature, and respiratory rate predicted COVID-19 diagnosis. Eosinopenia, neutrophilia, and lymphocytosis were also associated with COVID-19 diagnosis. However, asthma and COPD diagnoses were not associated with SARS-CoV-2 PCR positive test. Male gender, low oxygen saturation, and lower forced expiratory volume in 1 s (FEV(1)) were associated with higher hospital referral. Conclusions: CRD patients with acute respiratory symptoms in the ambulatory setting were more likely to have COVID-19 if male, febrile and tachypneic. Patients with lower pre-morbid FEV(1) and lower SPO(2) are more likely to be referred to the hospital. A composite of vitals sigs and WBC differential help risk stratify CRD patients seeking care for presumed COVID-19.

Clinic, prior to widely available testing, emergence of variants, 48 and post-vaccination (breakthrough) SARS-CoV-2 infections. Methods: Retrospective 49 electronic medical record data were analyzed from 907 adults with presumed COVID-19 50 seen between March 16, 2020 and January 7, 2021. Data included demographics, 51 comorbidities, medications, vital signs, laboratory tests, pulmonary function tests, 52 patient disposition, and co-infections. The overdispersed data (aod) R package was 53 used to create a logit model using COVID-19 diagnosis by PCR as the dichotomous 54 outcome variable. Univariate, conventional multivariate and elastic net machine 55 learning were used to analyze data. Results: Male gender, elevated baseline 56 temperature, and respiratory rate predicted COVID-19 diagnosis. Eosinopenia, 57 neutrophilia, and lymphocytosis were also associated with COVID-19 diagnosis. 58

However, asthma and COPD diagnoses were not associated with SARS-CoV-2 PCR 59 positive test. Male gender, low oxygen saturation, and lower forced expiratory volume 60 in one second (FEV1) were associated with higher hospital referral. SARS-CoV-2 continues to cause a global pandemic that has overwhelmed 69 emergency department (ED), hospital, and intensive care unit bed capacity (1). 70

Concerns regarding viral transmission at many ambulatory centers early in the 71 pandemic resulted in diversion of patients suspected of acute SARS-CoV-2 infection 72 to hospitals. While understanding of COVID-19 continues to improve, best 73 practices regarding ambulatory patient assessment and management during ongoing 74 transmission and viral mutation remain unclear. We describe ambulatory assessment 75 of patients with presumed National Jewish Health (NJH) is a subspecialty academic medical center that 77 cares for a population with high prevalence of underlying chronic respiratory disease 78 (CRD) including asthma, chronic obstructive pulmonary disease (COPD), and interstitial 79 lung disease (ILD); all of which were initially presumed to be risk factors for severe 80 COVID-19. CRD patients frequently experience respiratory exacerbations from many 81 etiologies, often indistinguishable from COVID-19. Persons at risk of severe COVID-19 82 illness (older age, chronic medical conditions), displaying fever or signs of lower 83 respiratory illness, met criteria for COVID-19 testing. To provide rapid assessment, 84 early triage, and hospital decompression, we designed an Acute Respiratory Clinic 85 (ARC) where presumed COVID-19 infections could be assessed. This unique resource 86 allowed us to study patients with CRD suspected of Although defining factors for COVID-19 severity in hospitalized patients were 88 identified (2-13), the risks of developing COVID-19 amongst ambulatory patients with 89 CRD, were less well appreciated. COPD and asthma were presumed to be associated 90 with severe COVID-19 amongst the hospitalized, resulting in high healthcare utilization 91 and morbidity/mortality (8, 14, 15) . However, others found that asthmatics actually may 92 have lower likelihood of COVID-19 severity (16). These discrepancies underscored our 93 unawareness of associations between CRD and COVID-19. 94

Using a retrospective analysis of data collected during regular care in the ARC, 95

we described easily identifiable clinical factors that could correlate with and predict 96 COVID-19 infection and/or hospitalization in those with CRD. We report the 97 demographic, clinical, and laboratory characteristics that distinguished COVID-19 from 98 exacerbations of underlying CRD in an ambulatory patient cohort and their disposition. 

This single-center retrospective cohort analysis was approved by the NJH 103 institutional review board, who waived requirement for consent when approving the 104 study. Study is retrospective review on electronic medical records (EMR) of 907 adult 105 patients (>18 years) seen in ARC between March 16, 2020 and January 7, 2021 ( Figure  106 1). Demographics, comorbidities, medications, vital signs, laboratory, and spirometry 107 were collected. Data were assembled from the NJH Research Database, 108 dataSCOUT TM , containing discrete and validated EMR information. 109

The ARC, with negative pressure rooms and dedicated entry/exit points, was 110 situated in a physically separate location from other clinical areas. Air exchanges 111 between patients was ensured and PPE donned by patients and providers. 112

Multidisciplinary providers with COVID-19 pandemic training attended to patients. 113

History was obtained and charting performed outside clinic rooms to limit exposure. 114

Disposition following initial ARC visit was decided by the treating clinician and defined 115 as: a) discharge home for self-isolation until COVID-19 results were obtained or b) 116 referral to higher level of care (local ED, direct hospital admission). 117

Laboratory data included blood analyses of complete blood count, metabolic 119 panel, liver function tests, and SARS CoV-2 real-time Polymerase Chain Reaction 120 (PCR) or end-point PCR followed by amplicon detection via mass-spectrometry. Other 121 respiratory pathogens were tested with multiplex respiratory pathogen panels ( limited set of predictor variables were used in the logit model based on those that were 137 likely to predict positivity (e.g., temperature, SPO2), respiratory rate (RR)). To compare 138 COVID-19 positive vs. negative populations, between-group differences of continuous 139 variables were tested by a pooled t-test or analysis of variance (JMP software, SAS 140

Pearson test, based on contingency tables. Tests and confidence intervals on odds 142 ratio (OR) were based on the Wald Test. Multivariable analysis was performed using 143 the glmnet algorithm. Candidate variables included 1) vital signs: heart rate (HR), 144 SPO2, RR, body temperature, systolic (SBP) and diastolic blood pressures (DBP); 2) 145 medical comorbidities; and 3) laboratory values: total white blood count (WBC), 146 neutrophils, lymphocytes, eosinophils, hemoglobin, blood urea nitrogen (BUN), 147 creatinine, sodium, aspartate aminotransferase (AST), alanine aminotransferase (ALT), 148 and total bilirubin. We also applied the elastic net as the method for the variable 149

selection (17), which addressed over-regularization by balancing between LASSO and 150 ridge penalty. The subjects were divided into 80:20 ratio for training and testing sets. 151

We first obtained the coefficients using the training set and calculated the area under 152 the curve (AUC) using the test set. Acceptable discrimination was defined as AUC 153 >0.70. The importance of the selected variable was estimated using the variable 154 importance plots (VIP). Subject characteristics are listed in Table 1 . Of the 907 patients, 154 tested 163 positive for SARS-CoV-2 (17%). Seven of the remaining 753 patients were not tested 164 because COVID-19 was deemed unlikely by the treating clinician. There were no 165 significant demographic differences between COVID-19 positive and negative groups. 166

Race and ethnic analyses were limited due to unavailable data for 31.2% of subjects. 167

Compared to SARS-CoV-2 negative patients, COVID-19 patients had higher 169 median temperature, lower SPO2, higher HR, higher RR, and lower SBP ( Table 2) . 170

Group analysis combining all vital signs resulted receiver operating characteristic curve 171 (ROC) AUC of 0.64 (Figure 2A) Table 2) . 181

Diagnosis of asthma, ILD, or COPD was not associated with testing positive for 183 COVID-19. Use of systemic/inhaled corticosteroids at the time of visit was not 184 correlated with COVID-19 diagnosis, nor was forced expiratory volume in first second 185 (FEV1) ( Table 2) . 186

Of the 154 patients with COVID-19, 135 (87.7%) were discharged home, 17 188 (11%) were referred to ED, and 12 (7.8%) were hospitalized. Most (10/12) hospitalized 189 subjects required supplemental oxygen above their baseline; two experienced 190 respiratory failure requiring ventilator support; and all survived to hospital discharge 191 (Figure 1) . There was no difference in age between those referred to the hospital 192 compared to those discharged home from the ARC. Men were referred to the hospital 193 at higher rates compared with women (LR p=0.05) but not hospitalized at a higher rate 194 Table 1) . The most represented CRD 207 was asthma, which was associated with higher likelihood of being referred to hospital 208 (LR, p<0.05). While COPD and ILD were not correlated with ED referral; the low 209 number of patients with these diagnoses limited our analysis. 210

689 of the total 907 (75.96%) subjects had testing for other respiratory viruses. 212

There was a relatively low prevalence of other viruses, with 6% of the COVID-19 group 213 (6/96) and 8% of the COVID-19 negative group (47/593) demonstrating positive RVP. 214

Chi-square and Fischer exact test were not significant between the two groups (p=0.500 215 and p=0.684, respectively). The lower prevalence of RVP positive results might be due 216 to social distancing measures during the time of study, resulting in low overall 217 transmission of other endemic viruses. 218

Conventional multivariate analysis of vital signs resulted in AUC of 0.64 for 220 discriminating between symptomatic individuals who were positive or negative for 221 COVID-19 (ROC curve, Figure 2) . Chi-square analysis for vital signs was significant 222 (p<0.0001). Group analysis of blood count and differential data resulted in AUC 0.69 223 infections. We found a set of factors that are associated with testing positive for SARS-246

CoV-2 PCR and possibly risk factors associated with hospital referrals. 247

Less than 1 in 5 patients in this cohort tested positive for SARS-CoV-2 and few 248 (12%) were referred to the ED and/or eventually hospitalized. Only 1% experienced 249 respiratory failure. Hypoxia was the most important factor determining hospital referral. 250

Those referred to the ED were more commonly male, non-Hispanic, had asthma 251 diagnosis and independent of asthma diagnosis had lower FEV1. 252

In our patient population of >60% with CRD, temperature, RR, WBC differentials 253 and AST correlated with COVID-19, with elevated temperature and eosinopenia 254 emerging as most influential. With increasing patient access to home monitoring of 255 SPO2, temperature and HR, an increase in median body temperature or HR could be 256 considered potentially useful screening tools. Lower WBC or eosinophils, in the context 257 of viral syndrome, could be useful in risk stratification if COVID-19 testing is limited. A 258 more important inference from our study is that CRD, in the absence of clinical 259 immunosuppression, did not emerge as a risk factor for testing positive for SARS-CoV-260

Asthma did not differentiate those who were eventually diagnosed with COVID-262 19, despite earlier studies predicting it to be a risk factor for viral disease based on 263 rhinoviral studies (22). In fact, asthmatics were represented in higher proportion in the 264 COVID-negative group. An early small study at the Hospital of Wuhan University and a 265 large multi-center heterogenous database in Israel also suggested that asthma is 266 unlikely to be a risk for SARS-CoV-2 infection (23, 24) . In fact, we found eosinopenia 267 associated with SARS-CoV-2 infection (Table 2) We did not observe higher associations of likelihood of SARS-CoV-2 infection or 273 increased hospital referrals with obesity, race, or ethnicity in our cohort. However, our 274 population was skewed towards higher White race reported, limiting our ability to detect 275 differences. SPO2 was lower in COVID-19 individuals but was not a key factor in 276 predicting COVID-19 in our outpatients. 277

Inherent to the study design, retrospective analysis was limited by data collected 279 in a real-world clinical environment, leading to information bias. Clinical judgment by 280 the treating clinician drives data collected. This led to some missing data and 281 incomplete analysis. However, the large number of subjects included in the study may 282 overcome some of these limitations. Effects of mixed race was also difficult to assess 283 with limited reporting. Objective data points would be less disparate between COVID-284 19 and non-COVID-19 subjects in the outpatient setting compared with a more severely 285 symptomatic inpatient population. Therefore, detecting these differences is more 286 difficult in the ambulatory setting. Additionally, the rapidly evolving nature of SARS-287

CoV-2 and demographics of affected patients, posed a particular challenge in the timing 288 of data collection, analysis, and publication of this study aimed to assist with 289 identification and prediction of COVID-19 in outpatient clinics at a time of limited testing. 290

Over the 9 months of data collection, there were changes affecting diagnostic and 291 treatment guidelines, prevalence in our community, and availability of rapid testing 292 amongst others. All these factors likely resulted in a different patient population in the 293 latter half of our data collection period. With the advent of COVID-19 vaccinations and 294 the emergence of novel variants, the demographic factors, vital signs, and laboratory 295 parameters associated with COVID-19 positive status may have changed further. 296

Strong associations and predictors of COVID-19 amongst ambulatory patients 298 with a high prevalence of chronic respiratory disease include male sex, increased 299 baseline temperature, and respiratory rate. Male sex, lower SPO2, and low FEV1 were 300 associated with hospital referrals. Asthma diagnosis did not emerge as a risk factor for Approval from institutional review board was obtained prior to initiation of the study. 321 Data analyzed on all available values. Of all 907 ARC patients seen between March 16, 338 2020 and January 7, 2021, 154 were diagnosed with COVID-19, of whom 135 were 339 discharged home. Fifteen were referred for ED evaluation and 10 hospitalized. There 340 is overlap between disposition to ED and Hospital. Of the 10 patients hospitalized, 7 341 were admitted from the ED, 2 were directly admitted, and 1 patient we could not 342 ascertain by which of these routes they were hospitalized. Additionally, one patient 343 seen in the ED refused admission. Missing data is noted in the figure. 344 diagnosis.

• Gender, relative pyrexia and tachypnea may predict SARS-CoV-2 PCR positive tests.

• Hospital referrals are influenced by oxygen saturation and pre-COVID spirometry.

J o u r n a l P r e -p r o o f

COVID-19) pandemic

Primary Care Relevant Risk Factors for Adverse 366 Outcomes in Patients With COVID-19 Infection: A Systematic Review

Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus 370 Disease

Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care 373 System

Hypertension, Diabetes and Obesity, Major Risk Factors for 376 Death in Patients with COVID-19 in Mexico

Primary Care Physicians ATSPoBI. Obesity is a Major 378 Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia. Mayo Clin 379 Proc

Pseudo-safety in a cohort of 381 patients with COVID-19 discharged home from the emergency department

Risk factors for hospital admissions related to COVID-19 in patients 384 with autoimmune inflammatory rheumatic diseases

Phenotypic 386 Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with 387 Diabetes and COVID-19: The DIABCOVID Study

Electronic 389 health record analysis identifies kidney disease as the leading risk factor for hospitalization in 390 confirmed COVID-19 patients

Predictors of mortality for 392 patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

Clinical course and outcomes of 395 critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, 396 retrospective, observational study. The Lancet Respiratory medicine

Clinical Characteristics, and Outcomes of a Large Cohort of COVID-19 Outpatients in 399 Michigan

The 401 impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East 402

Italy: results from COVIDEM network

COVID-19 Susceptibility in 404 Bronchial Asthma

Regularization and variable selection via the elastic net

COVID-19 in solid organ transplant recipients: A national cohort study from Sweden

Relationship of 411 socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 412 presentation and disease severity

COVID-19 dynamics after a 414 national immunization program in Israel

The 416 impact of vaccination on COVID-19 outbreaks in the United States

Frequency, 418 severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a 419 longitudinal cohort study

COVID-19 risk and outcomes in adult asthmatic patients 421 treated with biologics or systemic corticosteroids: Nationwide real-world evidence. The Journal 422 of allergy and clinical immunology

Clinical characteristics of COVID-19 424 patients combined with allergy

Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2

COVID-19, Asthma, and Inhaled Corticosteroids

Another Beneficial Effect of Inhaled Corticosteroids? American journal of respiratory and 430 critical care medicine

Type 2 432 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. The Journal of allergy 433 and clinical immunology

Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development 436 of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized 437 Clinical Trial

Antibody Combination and Outcomes in Outpatients with Covid-19

Early 442 Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Effect of 447 Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients 448 With Mild to Moderate COVID-19: A Randomized Clinical Trial